|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
¶ – Release Delayed to: 6/3/19 ·As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/01/19 Allstate Life Ins Co of New York POS AM¶ 116:15M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: POS AM Allstate Life Insurance Co of New York HTML 2.97M
116: CORRESP ¶ Comment-Response or Other Letter to the SEC HTML 35K
2: EX-23 Consent of Independent Registered Public HTML 33K
Accounting Firm
3: EX-24 Powers of Attorney HTML 58K
4: EX-99.(B) Experts HTML 32K
11: R1 Document and Entity Information HTML 46K
12: R2 Statements of Operations and Comprehensive Income HTML 101K
13: R3 Statements of Operations and Comprehensive Income HTML 43K
(Parenthetical)
14: R4 Statements of Financial Position HTML 155K
15: R5 Statements of Financial Position (Parenthetical) HTML 48K
16: R6 Statements of Shareholder's Equity HTML 55K
17: R7 Statements of Cash Flows HTML 119K
18: R8 General HTML 48K
19: R9 Summary of Significant Accounting Policies HTML 87K
20: R10 Supplemental Cash Flow Information HTML 45K
21: R11 Related Party Transactions HTML 44K
22: R12 Investments HTML 268K
23: R13 Fair Value of Assets and Liabilities HTML 302K
24: R14 Derivative Financial Instruments and Off-balance HTML 163K
sheet Financial Instruments
25: R15 Reserve for Life-Contingent Contract Benefits and HTML 112K
Contractholder Funds
26: R16 Reinsurance HTML 59K
27: R17 Deferred Policy Acquisition and Sales Inducement HTML 47K
Costs
28: R18 Guarantees and Contingent Liabilities HTML 43K
29: R19 Income Taxes HTML 64K
30: R20 Statutory Financial Information and Dividend HTML 39K
Limitations
31: R21 Benefit Plans HTML 36K
32: R22 Other Comprehensive Income HTML 52K
33: R23 Summary of Investments Other Than Investments in HTML 59K
Related Parties
34: R24 Reinsurance HTML 64K
35: R25 Valuation Allowances and Qualifying Accounts HTML 43K
36: R26 Summary of Significant Accounting Policies HTML 128K
(Policies)
37: R27 General (Tables) HTML 45K
38: R28 Supplemental Cash Flow Information (Tables) HTML 43K
39: R29 Investments (Tables) HTML 285K
40: R30 Fair Value of Assets and Liabilities (Tables) HTML 281K
41: R31 Derivative Financial Instruments and Off-balance HTML 161K
sheet Financial Instruments (Tables)
42: R32 Reserve for Life-Contingent Contract Benefits and HTML 120K
Contractholder Funds (Tables)
43: R33 Reinsurance (Tables) HTML 59K
44: R34 Deferred Policy Acquisition and Sales Inducement HTML 49K
Costs (Tables)
45: R35 Income Taxes (Tables) HTML 61K
46: R36 Other Comprehensive Income (Tables) HTML 52K
47: R37 General - Additional Information (Detail) HTML 36K
48: R38 Summary of Premiums and Contract Charges by HTML 52K
Product (Detail)
49: R39 Summary of Significant Accounting Policies - HTML 63K
Additional Information (Detail)
50: R40 Supplemental Cash Flow Information - Additional HTML 40K
Information (Detail)
51: R41 Schedule of Supplemental Cash Flow Information HTML 45K
(Detail)
52: R42 Related Party Transactions - Additional HTML 66K
Information (Detail)
53: R43 Schedule for Fixed Income Securities at Amortized HTML 72K
Cost, Gross Unrealized Gains and Losses and Fair
Value (Detail)
54: R44 Schedule for Fixed Income Securities Based on HTML 79K
Contractual Maturities (Detail)
55: R45 Schedule of Net Investment Income (Detail) HTML 58K
56: R46 Schedule of Net Investment Income (Parenthetical) HTML 41K
(Detail)
57: R47 Schedule of Realized Capital Gains (Losses) by HTML 51K
Asset Type (Detail)
58: R48 Schedule of Realized Capital Gains (Losses) by HTML 53K
Transaction Type (Detail)
59: R49 Investments - Additional Information (Detail) HTML 107K
60: R50 Schedule of Net Pre-Tax Appreciation (Decline) of HTML 41K
Equity Securities and Limited Partnership
Interests Carried at Fair Value Recognized in Net
Income (Detail)
61: R51 Schedule of Other-Than-Temporary Impairment Losses HTML 62K
by Asset Type (Detail)
62: R52 Schedule of Other-Than-Temporary Impairment Losses HTML 38K
on Fixed Income Securities included in Accumulated
Other Comprehensive Income (Detail)
63: R53 Schedule of Rollforwards of Cumulative Credit HTML 46K
Losses Recognized in Earnings for Fixed Income
Securities Held (Detail)
64: R54 Schedule of Unrealized Net Capital Gains and HTML 89K
Losses (Detail)
65: R55 Schedule of Change in Unrealized net Capital Gains HTML 63K
and Losses (Detail)
66: R56 Schedule of Change in Unrealized net Capital Gains HTML 37K
and Losses (Parenthetical) (Detail)
67: R57 Summary of Gross Unrealized Losses and Fair Value HTML 100K
of Fixed Income and Equity Securities by Length of
Time (Detail)
68: R58 Schedule of Commercial Mortgage Loans by HTML 48K
Geographic Distribution (Detail)
69: R59 Schedule of Types of Properties Collateralizing HTML 47K
Commercial Mortgage Loans (Detail)
70: R60 Schedule of Contractual Maturities of Mortgage HTML 63K
Loans (Detail)
71: R61 Summary of Carrying Value of Non-Impaired Mortgage HTML 55K
Loans by Debt Service Coverage Ration Distribution
(Detail)
72: R62 Schedule of Municipal Bonds Held For Investment by HTML 44K
Geographic Distribution (Detail)
73: R63 Fair Value of Assets and Liabilities - Additional HTML 70K
Information (Detail)
74: R64 Summary of Assets and Liabilities Measured at Fair HTML 129K
Value on Recurring and Non-Recurring Basis
(Detail)
75: R65 Summary of Quantitative Information About HTML 49K
Significant Unobservable Inputs Used in Level
Three Fair Value Measurements (Detail)
76: R66 Schedule of Rollforward of Level 3 Assets and HTML 159K
Liabilities Held at Fair Value on Recurring Basis
(Detail)
77: R67 Schedule of Rollforward of Level 3 Assets and HTML 53K
Liabilities Held at Fair Value on Recurring Basis
(Parenthetical) (Detail)
78: R68 Schedule of Change in Unrealized Gains and Losses HTML 62K
Included in Net Income for Level Three Assets and
Liabilities Held (Detail)
79: R69 Schedule of Carrying Values and Fair Value HTML 50K
Estimates of Financial Instruments not Carried at
Fair Value (Detail)
80: R70 Summary of Volume and Fair Value Positions of HTML 119K
Derivative Instruments and Reporting Location in
Statement of Financial Position (Detail)
81: R71 Schedule of Gross and Net Amount for Company's OTC HTML 78K
Derivatives Subject to Enforceable Master Netting
Arrangements (Detail)
82: R72 Summary of Gains and Losses from Valuation and HTML 65K
Settlements For Derivatives Not Designated As
Hedges (Detail)
83: R73 Derivative Financial Instruments and Off-balance HTML 40K
sheet Financial Instruments - Additional
Information (Detail)
84: R74 Summary of Counterparty Credit Exposure by HTML 44K
Counterparty Credit Rating (Detail)
85: R75 Derivatives Financial Instruments and Off Balance HTML 43K
Sheet Financial Instruments -Summary of Fair Value
of Derivatives (Detail)
86: R76 Derivatives Financial Instruments and Off Balance HTML 42K
Sheet Financial Instruments - Schedule of
Contractual Amounts of Off Balance Sheet Financial
instruments (Detail)
87: R77 Schedule of Reserve for Life-Contingent Contract HTML 50K
Benefits (Detail)
88: R78 Schedule of Key Assumptions Used In Calculation HTML 56K
Reserve for Life-Contingent Contract Benefits
(Detail)
89: R79 Reserve for Life-Contingent Contract Benefits and HTML 44K
Contractholder Funds - Additional Information
(Detail)
90: R80 Schedule of Contractholder Funds (Detail) HTML 46K
91: R81 Schedule of Contract Provisions Related to HTML 62K
Contractholder Funds (Detail)
92: R82 Schedule of Contractholder Funds Activity (Detail) HTML 51K
93: R83 Summary of Variable Annuity Contracts with HTML 58K
Guarantees (Detail)
94: R84 Summary of Liabilities for Guarantees (Detail) HTML 72K
95: R85 Summary of Liabilities for Guarantees HTML 57K
(Parenthetical) (Detail)
96: R86 Reinsurance - Additional Information (Detail) HTML 68K
97: R87 Schedule of Effects of Reinsurance on Premiums and HTML 48K
Contract Charges (Detail)
98: R88 Schedule of Effects of Reinsurance on Contract HTML 48K
Benefits (Detail)
99: R89 Schedule of Effect of Reinsurance on Interest HTML 46K
Credited to Contractholder Funds (Detail)
100: R90 Schedule of Deferred Policy Acquisition Costs HTML 47K
(Detail)
101: R91 Schedule of Deferred Sales Inducement Activity HTML 44K
(Detail)
102: R92 Guarantees and Contingent Liabilities - Additional HTML 40K
Information (Detail)
103: R93 Income Taxes - Additional Information (Detail) HTML 59K
104: R94 Components of Deferred Income Tax Assets and HTML 70K
Liabilities (Detail)
105: R95 Components of Income Tax Benefit Expense (Detail) HTML 44K
106: R96 Reconciliation of Statutory Federal Income Tax HTML 52K
Rate to Effective Income Tax Rate (Detail)
107: R97 Statutory Financial Information and Dividend HTML 49K
Limitations - Additional Information (Detail)
108: R98 Benefit Plans - Additional Information (Detail) HTML 40K
109: R99 Schedule of Components of Other Comprehensive HTML 85K
Income on Pre-Tax and After-Tax Basis (Detail)
110: R100 Schedule I - Summary of Investments Other Than HTML 96K
Investments in Related Parties (Detail)
111: R101 Schedule IV - Reinsurance (Detail) HTML 70K
112: R102 Schedule V - Valuation Allowances and Qualifying HTML 45K
Accounts (Detail)
114: XML IDEA XML File -- Filing Summary XML 228K
113: EXCEL IDEA Workbook of Financial Reports XLSX 158K
5: EX-101.INS XBRL Instance -- ck0000839759-20181231 XML 4.22M
7: EX-101.CAL XBRL Calculations -- ck0000839759-20181231_cal XML 350K
8: EX-101.DEF XBRL Definitions -- ck0000839759-20181231_def XML 1.65M
9: EX-101.LAB XBRL Labels -- ck0000839759-20181231_lab XML 2.07M
10: EX-101.PRE XBRL Presentations -- ck0000839759-20181231_pre XML 1.88M
6: EX-101.SCH XBRL Schema -- ck0000839759-20181231 XSD 342K
115: ZIP XBRL Zipped Folder -- 0001193125-19-094736-xbrl Zip 352K
| Acceleration Letter |
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| RE: | Acceleration Request – |
| Post-Effective Amendment No. 1 to Registration Statement on Form S-1 |
| File No. 333-224078 |
| Registrant: Allstate Life Insurance Company of New York |
| Principal Underwriter: Allstate Distributors, L.L.C. |
Members of the Commission:
Pursuant to Rule 461 of Regulation C under the Securities Act of 1933, acceleration of the above-referenced Post-Effective Amendment No. 1 to Registration Statement on Form S-1 is hereby requested to May 1, 2019.
Please direct any questions or comments to Angela K. Fontana at 847-402-9365. Thank you.
Very truly yours,
ALLSTATE LIFE INSURANCE COMPANY OF NEW YORK
ALLSTATE DISTRIBUTORS, L.L.C.
| /s/ Angela K. Fontana |
| Angela K. Fontana |
| Vice President, General Counsel and Secretary |
| This ‘POS AM’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 5/1/19 | None on these Dates | |||
| Filed on: | 4/1/19 | |||
| List all Filings | ||||